Eyeing the fast-growing medical device outsourcing market, CSSi has relaunched that arm of its business as a fully integrated CRO division.

China’s Pharmaron has picked up an R&D facility in the U.K. from Merck & Co. for an undisclosed lease amount. The move gives Pharmaron a growing…

San Diego- and China-based BioDuro, which merged with San Diego’s Formex late last year, announced at BIO this week its formal acquisition of Formex to form…

Rockville, MD’s ABL has inked its second candidate manufacturing partnership in as many weeks, signing on with Regenxbio to produce the biotech’s lead adeno-…

Charles River Laboratories International has dotted all the i's and crossed all the t's on its $585 million acquisition of WIL Research.

Privately-held CRO Snapdragon Chemistry is expanding its team, working space, corporate partnership and has elected in a new CEO in a major update from the…

Contract drugmaker Recipharm is promising to spend $45 million (€40 million) over the next three years to improve drug traceability in an effort to…

Onyx Scientific is set to increase the size of its U.K.-based site by more than 30% as it enjoys the spoils of a lucrative 2015.